Stay updated on TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Sign up to get notified when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.

Latest updates to the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page
- Check4 days agoChange DetectedRevision: v3.3.4 was added and v3.3.3 was removed.SummaryDifference0.0%

- Check11 days agoChange DetectedThe Publications section was updated to replace the TAGS Lancet Oncol 2018 paper citation with the version that includes the erratum. The prior non-erratum citation was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoNo Change Detected
- Check32 days agoChange DetectedAdded locations across the US (Arizona, California, Florida, Illinois, Kentucky, Michigan, New Hampshire, New York, North Carolina, Pennsylvania, Rhode Island, Texas, Wisconsin) and international sites (Bavaria, Chiba, Gunma, Ibaraki, Osaka, Tochigi, Toyama, Porto District, Setúbal District, Dolj, Middlesex, Scotland), and removed several previously listed locations along with the HHS Vulnerability Disclosure link.SummaryDifference1%

- Check54 days agoChange DetectedThe page footer revision label was updated from v3.3.1 to v3.3.2.SummaryDifference0.0%

- Check61 days agoChange DetectedThe Publications section now states that entries are automatically filled from PubMed with Revision: v3.3.1, replacing the previous wording about PubMed-generated lists (Revision: v3.2.0).SummaryDifference0.0%

- Check68 days agoChange DetectedThe government funding notice warning was removed from the page. This note previously warned that information might not be up to date and inquiries could be delayed during funding lapses.SummaryDifference0.2%

Stay in the know with updates to TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TAS-102 vs Placebo in Metastatic Gastric Cancer Clinical Trial page.